ROSEN, LEADING INVESTOR COUNSEL, Encourages Akero Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – AKRO

View Full Size 

Download

• Full Size JPEG, 2700x1000, 572.3 KB
• Small JPEG, 480x178, 123.1 KB
• Preview JPEG, 144x53, 36.8 KB
• Thumbnail JPEG, 120x44, 31.7 KB